Who Should Not Use GLP-1
Reeves, D
Recent developments include: Direct filing procedures allowing attorneys to efficiently add cases to the MDL Emphasis on objective testing requirements for gastroparesis claims, with the court making clear that diagnostic evidence strengthens cases Discovery orders requiring defendants to produce documents about their knowledge of gastrointestinal risks and their marketing practices Expert witness deadlines as both sides prepare to present medical and scientific testimony Bellwether trial schedules have not yet been finalized, but the litigation is progressing through pretrial phases
The result is typically more moderate weight loss compared to GLP-1s, but for many women, the appetite- and craving-control aspect makes it a helpful alternative or companion option depending on their needs
The decisive constraint is nutrient density inside a small, nausea-sensitive serving, which favors stick-packs, sachets, and ready-to-mix formats over large shakes
Youll need to meet a few eligibility requirements: You have a prescription for Mounjaro that aligns with FDA-approved uses (in this case, type 2 diabetes) You are covered by a commercial drug insurance plan You are not enrolled in any government-funded healthcare programs like Medicaid, Medicare, or the VA You live in the U.S
